Follow Us:

social twitter box white 32 social facebook box blue 32social linkedin box blue 32ISN Blog

Friday, 30 March 2012 13:44

Viper venom for diabetic nephropathy

By  Luiza Caramori, published in KI
Rate this item
(1 Vote)


Diabetic nephropathy is the leading cause of end-stage renal disease in the United States. Renin–angiotensin–aldosterone system (RAAS) blockers are thought to have a specific renoprotective effect in diabetes.

Hirst et al. report the results of randomized clinical trials assessing the effects of RAAS inhibitors on urinary albumin excretion levels in diabetic patients. Although reductions in urinary albumin excretion were observed, whether RAAS inhibitors offer additional protection over other antihypertensive agents is unclear.

This article is published in Kidney International: Kidney International (2012) 81, 615–616; doi:10.1038/ki.2011.460

Or, click here to read the full article...

Kidney International (2012) 81, 615–616; doi:10.1038/ki.2011.460

Additional Info

  • Language: English
  • Contains Audio: No
  • Content Type: Articles
  • Source: KI
  • Year: 2012
  • Members Only: No
Read 2525 times Last modified on Saturday, 22 March 2014 21:59

Leave your comments

Post comment as a guest

Your comments are subject to administrator's moderation.
terms and condition.

Global Operations Center

Rue des Fabriques 1
1000 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact


Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact